Cellebrite DI Ltd. CLBT
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | 15.77% | 18.13% | 17.94% | 18.35% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 15.77% | 18.13% | 17.94% | 18.35% | |
| Cost of Revenue | 42.60% | 11.72% | 31.53% | 8.71% | |
| Gross Profit | 10.81% | 19.37% | 15.64% | 20.32% | |
| SG&A Expenses | 19.88% | 16.69% | 27.27% | 21.49% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 25.62% | 15.74% | 22.45% | 18.78% | |
| Operating Income | -51.80% | 32.31% | -2.34% | 15.46% | |
| Income Before Tax | -46.19% | 32.03% | 111.87% | 194.44% | |
| Income Tax Expenses | 266.24% | 697.77% | 60.37% | -26.78% | |
| Earnings from Continuing Operations | -67.29% | 10.34% | 109.75% | 181.79% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -67.29% | 10.34% | 109.75% | 181.79% | |
| EBIT | -51.80% | 32.31% | -2.34% | 15.46% | |
| EBITDA | -6.73% | 34.10% | -1.69% | 12.92% | |
| EPS Basic | -68.27% | 2.42% | 108.35% | 167.67% | |
| Normalized Basic EPS | -47.87% | 25.52% | -- | 178.18% | |
| EPS Diluted | -67.96% | 1.78% | 108.06% | 166.17% | |
| Normalized Diluted EPS | -46.93% | 29.82% | -- | 175.43% | |
| Average Basic Shares Outstanding | 3.02% | 5.16% | 16.68% | 20.81% | |
| Average Diluted Shares Outstanding | 1.53% | 1.68% | 19.65% | 25.15% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |